Searchable abstracts of presentations at key conferences in endocrinology

ea0056p148 | Neuroendocrinology | ECE2018

Metastatic meduller thyroid cancer patient with MEN 2B who developed acute leukemia

Yorulmaz Goknur , Akalin Aysen , Kalkan Toygar , Sivrikoz Ilknur Ak , Gunduz Eren , Ceylan Ozgur

Introduction: Multiple endocrine neoplasia type 2B (MEN 2B) is an aggressive disorder characterized by medullary thyroid cancer (MTC) and pheochromocytoma. Peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE is an effective new treatment for inoperable or metastatic neuroendocrine tumors (NETs). Hematologic problems, myelodysplastic syndrome or leukemia can be seen after alkylating agent and peptide receptor radionuclide therapy treatments. We present metastatic m...

ea0073oc10.1 | Oral Communications 10: Thyroid | ECE2021

The role of VEGF expression in the development of papillary thyroid carcinoma in patients with lymphocytic thyroiditis

Gulcelik Nese Ersoz , Akın Şafak , Aydin Kadriye , Aydin Mericö Cisel , Usman Aydan

BackgroundVascular endothelial growth factor (VEGF) has been implicated in angiogenesis of papillary thyroid carcinoma (PTC). As VEGF expression is increased in PTC and even in lymphocytic thyroiditis (LT), we hypothesized that VEGF may play a role in the development of PTC in patients with LT. In order to find an association between VEGF and these disorders, we examined both the tumoral and adjacent tissues of PTC patients with and without LT.<p cla...

ea0099oc13.2 | Oral Communications 13: Late Breaking | ECE2024

Assessment of mitochondrial peptide humanin in women with polycystic ovary syndrome: Serum and skeletal muscle profile

Sonmezoglu Kutuk Irem , Akı Senay , Demirel Ali Haydar , Mumusoglu Sezcan , Ciftci Turkmen Turan , Yildiz Bulent

Background and Aim: Humanin is a mitochondria-derived peptide (MDP) secreted in response to oxidative stress and linked to diverse cellular processes including inflammation and insulin resistance. Humanin has been shown to be downregulated in polycystic ovaries and exogenous humanin supplementation has attenuated insulin resistance and ovarian morphological abnormalities in a PCOS rat model. The aim of this study was to investigate the role of humanin in the pathophysiology of...

ea0099ep462 | Pituitary and Neuroendocrinology | ECE2024

Difficulties in treating acromegaly: what treatment? when to start?

Eraslan Aydemir Esra , Başak Tan Oksuz Sinem , Gullu Sevim

Introduction: Acromegaly is a disorder caused by excessive secretion of growth hormone, often due to pituitary masses. The first step in treatment is transsphenoidal surgery. Cabergoline, somatostatin receptor ligands or pegvisomant may be used in patients with an inadequate response after surgery. Finally, radiotherapy may be used in patients with inadequate response to medical treatment.Methods: In this retrospective study, data of 89 patients (59 fema...

ea0073aep894 | Late Breaking | ECE2021

Radioactive iodine therapy with recombinant human TSH (rhTSH) for well-differentiated thyroid cancer had no difference in GO outcome; case report

Faki Sevgul , Deniz Serdar , Burçak Cavnar Helvacı , Çağlar Keskin , Burçak Polat , Nilay Yüksel , Şeyda Türkölmez , Oya Topaloğlu , Ersoy Reyhan , BekirÇakir

BackgroundThe risk of cancer is relatively higher in Graves’ patients presenting simultaneously with thyroid nodules. Radioiodine (RAI) therapy recommended in intermediate-high risk differentiated thyroid carcinoma may be associated with worsening of a pre-existing Graves’ orbitopathy (GO) or developing a new onset. The impact of RAI therapy in patients with differentiated thyroid cancer on the course of a pre-exisiting GO has not been specific...

ea0070aep137 | Bone and Calcium | ECE2020

Are young primary hyperparathyroidism patients differ from older ones regarding clinical and biochemical features?

Burçak Polat Şefika , Evranos Ogmen Berna , Ozdemir Didem , Topaloglu Oya , Ersoy Reyhan , Cakir Bekir

Introduction: Primary hyperparathyroidism (PHPT) is a prevalent endocrinologic disease and the most common cause of hypercalcemia. PHPT usually affects the elderly. PHPT younger than 40 years of age is less frequent. In young patients especially for ones younger than 30 years of age, screening for familial syndromes such as MEN 1 and MEN 2A is recommended. However, in most of the cases genetic tests are negative and evidence for other endocrine components are absent. Herein th...

ea0011p848 | Thyroid | ECE2006

Towards the development of a valid quality of life questionnaire for patients with thyroid diseases: Which questions shall we ask?

Watt T , Groenvold M , Rasmussen AK , Bonnema SJ , Hegedüs L , Bjorner JB , Feldt-Rasmussen U

Background and aim: In clinical populations, generic quality of life (QoL) questionnaires should be supplemented with disease-specific questionnaires, which may have higher sensitivity and clinical relevance. For the purpose of developing a comprehensive thyroid QoL questionnaire, we have evaluated the relative importance of various QoL aspects to thyroid patients.Methods: A list of problems (issues) related to thyroid diseases, previously identified thr...

ea0011p901 | Thyroid | ECE2006

Hashimoto’s thyroiditis in the children: clinical features at presentation

Skarpa VT , Kostakioti ED , Tertipi AK , Petrou PA , Posnaghidou E , Anastasakou M , Papahilleos P , Papathanasiou A , Hadjiathanasiou C

Hashimoto’s thyroiditis (HT) is the most frequent thyroid disease in children, in areas of the world with sufficient iodine intake.Aim: To study the clinical features of HT in children at presentation.Material and method: We studied 99 children with HT, 76 (76.8%) girls and 23 (23.2%) boys, with mean chronological age 10.7±2.6 ys (3.2–15.6 ys). The diagnosis of HT was established from the high titers of antithyroid a...

ea0011p910 | Thyroid | ECE2006

Changes in thyroxine requirement in the long-term follow-up of hypothyroid patients

Viswanath AK , Avenell A , Philip S , Acharya S , MacLennan G , Dalziel K , Copland SA , Bevan JS , Abraham P

Background and methodology: There are few data on changes in thyroxine requirement in the long-term follow-up of hypothyroid patients. We carried out a retrospective analysis to evaluate the long-term changes in thyroxine dose and its relationship with age, gender, thyroxine dose at registration and aetiology of hypothyroidism.Results: We identified 5,029 patients from our hospital based thyroid register with a minimum of 4 years follow-up (88% female, 7...

ea0011p913 | Thyroid | ECE2006

What is the most effective screening interval in the long-term follow-up of stable hypothyroid patients on thyroxine?

Viswanath AK , Avenell A , Philip S , Acharya S , MacLennan G , Dalziel K , Pereira O , Copland SA , Bevan JS , Abraham P

Background and methodology: In the long-term surveillance of treated hypothyroid patients, annual surveillance (with thyroid function testing) is widely recommended. This is largely based on consensus, as there is limited evidence to support this practice. Currently around 20,000 patients are registered in our hospital based thyroid register and the majority are on 18 monthly follow-up. We carried out a retrospective analysis to see if there is evidence to support increased fr...